Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Investigating the Role of Von Willebrand Factor (VWF) in Modulating In Vivo angiogenesis in VWF-Deficient Mice

Edwin K. Ocran, Erin Burnett, Mackenzie L. Bowman, Orla Rawley, Matthew Cormier, Donald Maurice, David Lillicrap, Paula D. James

Blood (2022) 140 (Supplement 1): 11222–11223.

https://doi.org/10.1182/blood-2022-159053

Published: 2022

Journal Articles

Take Control. Period. -Interactive Patient Education Website Enhances Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Savannah Norman, Ying Ling, Meffe Filomena, Shamshah Aratia, Deborah Robertson, Aziz Jiwajee, Grace Tang, Paula D. James, Jeff Mosko, Michelle Sholzberg

Blood (2022) 140 (Supplement 1): 1623–1624.

https://doi.org/10.1182/blood-2022-167945

Published: 2022

Journal Articles

The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease

Michelle Sholzberg, Grace H Tang, Paula D. James, Filomena Meffe, Emily Rimmer, Shannon Jackson, Haowei Linda Sun, Sue Robinson, Georgina Floros, Shamshah Aratia, Peter Jüni, Bruno R. da Costa

Blood (2022) 140 (Supplement 1): 8483–8484.

https://doi.org/10.1182/blood-2022-168675

Published: 2022

Journal Articles

A Major Knowledge Gap in Women's Health: The Combined Effect of Antifibrinolytics and Estrogen on Risk of Thromboembolism - a Scoping Review

Danielle Meschino, MD, Daniel Lindsay, Grace H Tang, MSc, Paula D. James, MDFRCPC, Michelle Sholzberg, MDM, FRCPC, MSc

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-142175

Published: 2020

Journal Articles

Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Ying Ling, BMSc, MD, Filomena Meffe, MD MSc, Deborah Robertson, MD, Jessica Petrucci, MSc, Georgina Floros, RN, Paula D. James, MD, Jeffrey Mosko, MD MSc, Michelle Sholzberg, MDBSc,FRCPC,MSc

Blood (2019) 134 (Supplement_1): 5868.

https://doi.org/10.1182/blood-2019-122521

Published: 2019

Journal Articles

Reducing Unnecessary Coagulation Testing in Outpatients (REDUCTION): A Quality Improvement Project

Fatima Khadadah, MBBS, Aziz Jiwajee, Hina Chaudhry, BSc, Paula D. James, MD, Rosane Nisenbaum, PhD, Rajesh Girdhari, MD, Curtis Handford, MD, Jonathan Hunchuck, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2018) 132 (Supplement 1): 4703.

https://doi.org/10.1182/blood-2018-99-113694

Published: 2018

Journal Articles

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Alberto Tosetto, Pamela A Christopherson, Jeroen C.J. Eikenboom, MD, Julie Grabell, CCRP, Paula D. James, MD, Robert R Montgomery, MD, Ian Peake, PhD, Mariana Silva, MD FRCPC, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 1180.

https://doi.org/10.1182/blood-2018-99-115728

Published: 2018

Journal Articles

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Sandra L Haberichter, PhD, Jorge Di Paola, MD, Paula D. James, MD, Janna M. Journeycake, MD, Steven R. Lentz, MD PhD, Cindy A. Leissinger, MD, Margaret V. Ragni, MD MPH, Madhvi Rajpurkar, MD, Jonathan C. Roberts, MD, Amy Shapiro, Robert F. Sidonio, Robert R Montgomery, MD, Thomas C. Abshire, MD

Blood (2018) 132 (Supplement 1): 979.

https://doi.org/10.1182/blood-2018-99-110650

Published: 2018

Journal Articles

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Jessica Garcia, MD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Paula D. James, MD, Pippa Simpson, PhD, Liyun Zhang, MS, Thomas C. Abshire, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 1075.

https://doi.org/10.1182/blood.V130.Suppl_1.1075.1075

Published: 2017

Journal Articles

Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years

Jessica Bui, BHSc, David Martyres, Paula D. James, MD, Julie Grabell, CCRP, John K. Wu, MBBS, FRCPC, MS, MacGregor Steele, MD FRCP(C), Mariana Silva, MD FRCPC, Margaret L. Rand, PhD, Victor S. Blanchette, MD, Robert J Klaassen, MD FRCPC

Blood (2017) 130 (Supplement 1): 2135.

https://doi.org/10.1182/blood.V130.Suppl_1.2135.2135

Published: 2017

Journal Articles

Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?

Nicola Goldberg, MD, Rosane Nisenbaum, PhD, Hong Song, David Lillicrap, MD FRCPC, Jerome M. Teitel, MD FRCPC, Paula D. James, MD, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2017) 130 (Supplement 1): 3681.

https://doi.org/10.1182/blood.V130.Suppl_1.3681.3681

Published: 2017

Journal Articles

Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?

Jordan Spradbrow, BSc, Sasha Letourneau, Julie Grabell, CCRP, Yupu Liang, PhD, James Riddel, RN, MS, CPNP, Wilma Hopman, MSc, Victor S. Blanchette, MD, Margaret L. Rand, PhD, Barry S. Coller, MD, Andrew D. Paterson, MD, Paula D. James, MD

Blood (2017) 130 (Supplement 1): 2369.

https://doi.org/10.1182/blood.V130.Suppl_1.2369.2369

Published: 2017

Journal Articles

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Michelle Lavin, MB FRCPath, Sonia Aguila, PhD, Sonja Schneppenheim, MD, Niall Dalton, BSc, Jamie M O'Sullivan, PhD, Niamh M O'Connell, MB, FRCPath, PhD, Kevin M. Ryan, MB, Mary Byrne, MSc, Margaret Nolan, BSc, Roger Preston, PhD, Ulrich Budde, MD, Paula D. James, MD, Jorge Di Paola, MD, James S O'Donnell, MD PhD

Blood (2016) 128 (22): 873.

https://doi.org/10.1182/blood.V128.22.873.873

Published: 2016

Journal Articles

Let's Talk Period: Preliminary Results of an Online Bleeding Awareness Knowledge Translation Project and Bleeding Assessment Tool Promoted on Social Media

Emily A Reynen, MDM, PharmD, Julie Grabell, BA, CCRP, Paula D. James, MD

Blood (2016) 128 (22): 3775.

https://doi.org/10.1182/blood.V128.22.3775.3775

Published: 2016

Journal Articles

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Natasha Amrita Satkunam, MBBS, MSc, Johnny Mahlangu, MD, Christoph Bidlingmaier, MD PD, Dr. MD, Maria Eva Mingot-Castellano, PhD, Meera B. Chitlur, MD, Patrick F. Fogarty, MD, Adam Cuker, MD MS, Maria Elisa Mancuso, MD PhD, Pal André Holme, PhD MD, Julie Grabell, BA, CCRP, Wilma Hopman, MA, Prasad Mathew, MD, Paula D. James, MD

Blood (2016) 128 (22): 875.

https://doi.org/10.1182/blood.V128.22.875.875

Published: 2016

Journal Articles

Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)

Lidia Cosentino, PhD, Paula D. James, MD, Michelle Sholzberg, MDM, MSc, Alfonso Iorio, MD PhD

Blood (2016) 128 (22): 2593.

https://doi.org/10.1182/blood.V128.22.2593.2593

Published: 2016

Journal Articles

Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism

Lindsey Hawke, Mackenzie L. Bowman, Man-Chiu Poon, Mary-Frances Scully, Georges-Etienne Rivard, Paula D. James

Blood (2016) 128 (4): 584–593.

https://doi.org/10.1182/blood-2015-10-678052

Published: 2016

Includes: Supplemental data

Journal Articles

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Blood (2016) 127 (20): 2481–2488.

https://doi.org/10.1182/blood-2015-10-673681

Published: 2016

Includes: Supplemental data

Journal Articles

VWD diagnosis: improved

Paula D. James

Blood (2016) 127 (20): 2372–2373.

https://doi.org/10.1182/blood-2016-03-703231

Published: 2016

Journal Articles

Testing for Heparin Induced Thrombocytopenia: Comparison of Practice at an Academic Center with Choosing Wisely Guidelines

DiMaria C Erica, MD, Alex Trussler, MD, Dyba Janique, MD, David Lee, MD FRCPC, Michael J. Rauh, MD PhD, Paula D. James, MD FRCPC, Wilma Hopman, MA, Annette E Hay, MB ChB

Blood (2015) 126 (23): 3469.

https://doi.org/10.1182/blood.V126.23.3469.3469

Published: 2015

NARROW

Investigating the Role of Von Willebrand Factor (VWF) in Modulating In Vivo angiogenesis in VWF-Deficient Mice

Take Control. Period. -Interactive Patient Education Website Enhances Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease

A Major Knowledge Gap in Women's Health: The Combined Effect of Antifibrinolytics and Estrogen on Risk of Thromboembolism - a Scoping Review

Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Reducing Unnecessary Coagulation Testing in Outpatients (REDUCTION): A Quality Improvement Project

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years

Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?

Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Let's Talk Period: Preliminary Results of an Online Bleeding Awareness Knowledge Translation Project and Bleeding Assessment Tool Promoted on Social Media

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)

Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

VWD diagnosis: improved

Testing for Heparin Induced Thrombocytopenia: Comparison of Practice at an Academic Center with Choosing Wisely Guidelines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only